Have you or your loved ones been diagnosed with community-acquired pneumonia?

You may be eligible to participate in a community-acquired pneumonia clinical trial.

Have you or your loved ones been diagnosed with community-acquired pneumonia? You may be eligible to participate in a community-acquired pneumonia clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Community-acquired Pneumonia Clinical Trial in Argenteuil
NCT01963442 | Phase 2 | Interventional
Versailles Hospital
Sponsored by
Versailles Hospital

Have you or your loved ones been diagnosed with community-acquired pneumonia?

You may be eligible to participate in a community-acquired pneumonia clinical trial.

Have you or your loved ones been diagnosed with community-acquired pneumonia? You may be eligible to participate in a community-acquired pneumonia clinical trial.

Recruiting

Male & Female

18 Years +

This study is looking to recruit 310 Participants

To investigate the non inferiority of a short lasting antibiotic treatment (3 days) when compared to a long lasting antibiotic treatment (8 days), at Day 15 after the beginning of treatment in terms of clinical efficacy, in adults admitted to emergency services for a non severe Community Acquired Pneumonia (PAC), who responded well to 3 days of beta-lactamin treatment (3GC or A/AC).